A Great Fiducial Marker
Palliative marker-based SBRT
Gold Anchor as a reference for an earlier field border in a new metastasis close to earlier treatment.
Target tumors with greater precision
Stereotactic Body Radiation Therapy (SBRT) is increasingly being used in palliative care to manage metastatic or advanced cancers. Unlike conventional palliative radiotherapy, SBRT delivers highly focused, high-dose radiation to specific tumors, often in fewer sessions. This approach can effectively relieve pain, control tumor growth, and, in some cases, extend the survival of patients by delaying disease progression. By targeting tumors with greater precision, SBRT minimizes damage to surrounding healthy tissues, making it especially suitable for patients with limited treatment options or multiple comorbidities.
Enable real-time tumor tracking during treatment
The ability of SBRT to deliver pinpoint accuracy is crucial in palliative settings, where the goal is to maximize quality of life. Here, fiducial markers play a vital role. Implanted near or within the tumor, these small, radiopaque markers act as reference points that enable real-time tumor tracking during treatment. They are especially beneficial for tumors located in areas prone to motion, such as the lungs, liver, or pancreas, where breathing or other physiological movements can compromise targeting accuracy.
Pancreatic cancer treatment. Circles indicates five days inter-fraction tumor movement during SBRT treatment.
Safely reduce treatment margins
By improving localization and motion management, fiducial markers allow clinicians to safely reduce treatment margins, sparing more healthy tissue while ensuring the tumor receives the prescribed dose. This precision not only enhances treatment effectiveness but also reduces side effects, ensuring a better overall experience for the patient. In palliative care, where minimizing discomfort and maximizing treatment efficiency are paramount, the integration of fiducial markers with SBRT represents a significant advancement in improving patient outcomes.
Man weighing 170 kilograms, 375 pound, with kidney cancer.
Gold Anchor as a reference for the caudal field border in a rectal cancer treatment.